CYTK

Cytokinetics, Incorporated $73.77 1M -2.5% 3M +6.5% YTD +19.5% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.4%
Next 1 week
+0.1%
Next 1 month
-0.6%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -5.0% median, 38% of the last 21 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 46
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.05%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.90 -0.1% · Seasonal tilt -0.4%
$129M/day volume 45% volatility +42% 1-year -33% from ATH
52-week range · 65% of the way up · -16% from the high
$47.22$88.31

Congressional trades in CYTK Full tracker →

2 members · 3 buys / 1 sells · $4K–$60K disclosed · latest filing Jul 2, 2026.

BUY GC Gilbert Cisneros · traded Jun 30, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Oct 9, 2025 $1K–$15K
BUY LM Lisa McClain · traded Jun 11, 2025 $1K–$15K
SELL LM Lisa McClain · traded Jun 17, 2025 $1K–$15K

Earnings Full history →

Next report 2026-11-05 (Thursday, after close, in 52 days) · EPS est. -1.43.

1-day std dev
7.4%
Finished up
40%
Biggest pop
+26.1%
Biggest drop
-13.7%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.